|  |  |  |  | 
| Country | Region | Reference | Comments | 
| Bulgaria | Sofia | 1 | IDUs in drug treatment centre. Acute and chronic cases. Unique identifier. Laboratory confirmation. Case definition: ELISA Bio-Rad was used, all positive samples were confirmed by confirmatory testing. | 
|  |  |  |  | 
| Czech Republic | NATIONAL | 1 | Acute cases. No unique identifier. Laboratory confirmation. HBeAg results collected. Case definition: In symptomatic cases clinical picture compatible with hepatitis, e.g. discrete onset of symptoms and jaundice or elevated serum aminotransferate level. Laboratory confirmation in symtpomatic and asymptomatic cases: IgM anti HB, antibodies HBV nucleic acid in serum. | 
|  |  |  |  | 
| Denmark | NATIONAL | 4 | Acute cases. Unique identifier. Laboratory confirmation. HBeAg results collected. | 
|  |  |  |  | 
| Estonia | NATIONAL | 1 | Acute cases. Unique identifier. Laboratory confirmation. No HBeAg results. Case definition: Clinical picture compatible with hepatitis discrete onset of symptoms and jaundice or elevated serum aminotransfrase levels and a case is laboratory confirmed. | 
|  |  |  |  | 
| Latvia | NATIONAL | 3 | Acute cases. HBeAg results are collected. | 
|  |  |  |  | 
| Luxembourg | NATIONAL | 1 | Note: all notified hepatitis C cases, IDU cases not available. Acute and chronic cases. Unique identifier. Laboratory confirmation. HBeAg results collected. | 
|  |  |  |  | 
| Hungary | NATIONAL | 1 | Acute cases. Unique identifier. Laboratory confirmation. No HBeAg results. Case definition: An illness with discrete data of onset, and (2) jandince or elevated serum aminotransferase levels greater than 2,5 times the upper limit of normal. Serologic criteria used: HBsAg-positive, or/and anti HBcIgM positive: with IgM antiHAV-negative or not done. | 
|  |  |  |  | 
| Netherlands | NATIONAL | 19 | Acute and chronic cases. No unique identifier. No laboratory confirmation. No HBeAg results collected. Case definition: until 1-4-99: acute, symptomatic HBV infection, from 1-4-'99 onwards: newly diagnosed HBV infection (acute & chronic). | 
|  |  |  |  | 
| Poland | POMORSKIE Gdansk | 3 | na | 
|  |  |  |  | 
| Slovenia | NATIONAL | 1 | Acute cases. Unique identifier. Laboratory confirmation. HBeAg results collected. Case definition: a suspected case which is laboratory confirmed (HBsAg positive or IgM anti HBc positive and IgM anti HAV neg. and anti HCV neg.) | 
|  |  |  |  | 
| Slovakia | BRATISLAVA REGION | 1, 4 | na | 
|  |  |  |  | 
| Finland | NATIONAL | 1a | Acute cases. Unique identifier. Laboratory confirmation. No HBeAg results. | 
|  |  |  |  | 
| Sweden | NATIONAL | 3 | Acute cases. Unique identifier. Laboratory confirmation. No HBeAg results. Case definition: Case of acute HBV infection: HBsAg positive, anti-HBcIgM positive. | 
|  |  |  |  | 
| UK | ENGLAND AND WALES | 23, 26 | Acute cases. Unique identifier. Laboratory confirmation. No HBeAg results collected. Case definition: HBsAg positive and anti-HBc IgM positive and/or with discrete onset of jaundice or other comparable symptoms. | 
|  |  |  |  | 
|  | SCOTLAND | 27 | Laboratory confirmation. Case definition: laboratory reports of positive hepatitis B Virus (HBV) tests - any marker. Note: Information on risk factors, clinical history and status of HBV markers is frequently missing, thus it is difficult to determine whether cases are acute or chronic. | 
|  |  |  |  | 
|  | NORTHERN IRELAND | 25 | Acute and chronic cases. No unique identifier. Laboratory confirmation. HBeAg results collected. Case definition: all acute cases of hepatitis should be reported; chronic infections should also be reported when occurring in children, pregnant women and health care workers. | 
|  |  |  |  | 
| Norway | NATIONAL | 7 | Acute and chronic cases. Unique identifier. Laboratory confirmation. HBeAg results are collected. Case definition: clincal picture compatible with hepatitis and detection of HBs antigen / HBV-RNA or IgM antibodies to hepatitis B core antigen (anti-HBc) positive or detection of HBV-DNA in serum or seroconvertion during the last 12 months. | 
|  |  |  |  |